CheckCap (CHEK)
(Delayed Data from NSDQ)
$2.25 USD
-0.05 (-2.17%)
Updated May 2, 2024 03:50 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Check-Cap Ltd. [CHEK]
Reports for Purchase
Showing records 21 - 40 ( 79 total )
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Financing Completed; U.S. Pivotal Trial Starts Soon; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Check-Cap Ltd.
Industry: Medical - Instruments
We Spoke to Soon Check-Cap Raises Capital and Dilutes the stock-Again We Are Not Sure Why?
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Check-Cap Ltd.
Industry: Medical - Instruments
U.S. Pivotal Trial Protocol Approved; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Raising to Buy- U.S. Phase 3 Pivotal Trial Set to Begin
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Check-Cap Ltd.
Industry: Medical - Instruments
U.S. Pivotal Trial of C-Scan May Start Soon; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Neutral 3Qtr Results: $57M in Cash, 95M shares Outstanding
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Company: Check-Cap Ltd.
Industry: Medical - Instruments
2Q21 Results; Financing Completed; Adjusting PT to $3 Due To Dilution
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Neutral Dilution: Raises Capital (at the low) 25+25 New Shares
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Lowering to Neutral from Buy as we wait for Pivotal Study
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Check-Cap Ltd.
Industry: Medical - Instruments
FDA Approves C-Scan Pivotal Trial Application; Reiterate Buy; Raising PT to $4
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Check-Cap Ltd.
Industry: Medical - Instruments
3Q20 Financial Results Reported; Reiterate Buy; Lowering PT to $1.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Company: Check-Cap Ltd.
Industry: Medical - Instruments
1Q20 Results; Additional Financing Completed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y